ECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logoECOG-ACRIN logo
  • Home
  • Archives
  • Contact
✕
  • Filter by
  • Categories
  • Tags
  • Authors
  • Show all
  • All
  • Advocacy
  • Anal cancer
  • Artificial intelligence (AI)
  • Bladder cancer
  • Brain cancer
  • Breast cancer
  • Colorectal cancer
  • ComboMATCH
  • Esophagus cancer
  • Gallbladder cancer
  • Head and neck cancer
  • Health equity
  • Immunotherapy
  • In memory
  • Kidney cancer
  • Leukemia
  • Liver cancer
  • Lung cancer
  • Lymphoma
  • Mammography
  • Melanoma
  • Myelodysplastic syndrome
  • Myeloma
  • NCI-MATCH
  • Older adults
  • Pancreatic cancer
  • Pancreatic cysts
  • Patient education
  • Patient navigation
  • Patient-reported outcomes
  • Penis cancer
  • Personalized treatment
  • Policy
  • Precision medicine
  • Prevention
  • Prostate cancer
  • Real-world data/evidence
  • Research results
  • Sarcoma
  • Screening for cancer
  • Side effects
  • Survivorship
  • Targeted therapy
  • Upper tract urothelial cancer
  • Young adults
March 23, 2023
Person walking on directional sign
March 23, 2023
Categories
  • Editorials

Should I stay or should I go?

Many patients are unaware that stopping treatment during participation in a clinical trial does not automatically mean withdrawing from a clinical trial
Do you like it?
0 Read more
March 24, 2022
Woman with pill bottle
March 24, 2022
Categories
  • Editorials

Come again? Communicating clearly about risk of recurrence after early-stage breast cancer

Mary Lou Smith and colleagues at the Research Advocacy Network recently explored how well patients with early-stage breast cancer understand risk of their cancer coming back
Do you like it?
0 Read more
September 20, 2021
Jill Feldman and Kristin Ito headshots
September 20, 2021
Categories
  • Editorials

The language of (lung) cancer

A new language guide encourages respect, eliminates blame, and promotes health equity
Do you like it?
0 Read more
June 24, 2021
Mary Lou Smith, JD at podium
June 24, 2021
Categories
  • Editorials

Advocacy and the NCI’s National Clinical Trials Network

Advocates play an important role in each of the NCTN groups, helping to inform the design and implementation of clinical trials
Do you like it?
0 Read more
Prev page
12

Office of Communications
1818 Market Street, Suite 3000
Philadelphia, PA 19103
Phone: 215.789.3631
www.ecog-acrin.org

Contact us with any questions

© 2019-2026 ECOG-ACRIN Cancer Research Group. All Rights Reserved. Designed by Create & Associates, Inc